期刊
EMBO JOURNAL
卷 31, 期 13, 页码 2952-2964出版社
WILEY
DOI: 10.1038/emboj.2012.122
关键词
cell cycle; cell stress; cell survival; p38 SAPK; p57 CDKi
资金
- MICINN (Spanish Government)
- 'Juan de la Cierva' program
- MICINN [BFU2007-66503, BFU2010-15839, BIO2009-07762]
- Consolider Ingenio 2010 programme [CSD2007-0015]
- European Commission [ERAS-CT-2003-980409]
- DG Research
- FP6 as part of an EURYI scheme award
- Fundacion Marcelino Botin
- ICREA Academia (Generalitat de Catalunya)
- ICREA Funding Source: Custom
The p57(Kip2) cyclin-dependent kinase inhibitor (CDKi) has been implicated in embryogenesis, stem-cell senescence and pathologies, but little is known of its role in cell cycle control. Here, we show that p57(Kip2) is targeted by the p38 stress-activated protein kinase (SAPK). Phosphorylation of p57(Kip2) at T143 by p38 enhances its association with and inhibition of Cdk2, which results in cell-cycle delay upon stress. Genetic inactivation of the SAPK or the CDKi abolishes cell-cycle delay upon osmostress and results in decreased cell viability. Oxidative stress and ionomycin also induce p38-mediated phosphorylation of p57 and cells lacking p38 or p57 display reduced viability to these stresses. Therefore, cell survival to various stresses depends on p57 phosphorylation by p38 that inhibits CDK activity. Together, these findings provide a novel molecular mechanism by which cells can delay cell cycle progression to maximize cell survival upon stress. The EMBO Journal (2012) 31, 2952-2964. doi: 10.1038/emboj.2012.122; Published online 8 May 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据